Tag Archives: Medical Devices

Trending: Wearables and Invisibles

I can’t help imagining the cocktail party of 2018 as a scene from one of those a low-budget sci-fi film aired late at night. Imagine: A living room packed with people too busy to chat with each other as they balance their drinks with one hand and monitor their sleeves of devices and smartphones with […]
Posted in Op-Ed, Technology | Also tagged , , | Leave a comment

Mind the (Generation) Gap: The Hunt for Talent in Asia

As more global life sciences firms see their Asian businesses skyrocket, the search for strong, internationally savvy talent in Asia-Pacific has never been more competitive, writes Susan Macdonald of RSA. The need to build manufacturing and commercial infrastructure in Asia-Pacific with the associated regulatory, quality and compliance processes to satisfy Western authorities is reaching new […]
Posted in Emerging Markets, Global, Guest Blog, leadership | Also tagged , , , | Leave a comment

Mexico’s Healthcare Market Value “to Reach Almost $28 Billion by 2020″

Mexico’s pharmaceutical industry will be worth approximately US$22.5 billion by 2020, according to research and consulting firm GlobalData. Combined with the medical devices industry — expected to be worth US$5.4 billion by the same time — the total value of Mexico’s healthcare market value will be $27.9 billion. GlobalData reports that this overall increase in Mexico’s […]
Posted in Emerging Markets, Global | Also tagged , , | Leave a comment

The First Footfall: What Apple’s “HealthKit” Announcement Means to Healthcare

By Bill Drummy, Pharm Exec Editorial Advisory Board. Among the many announcements Apple made earlier this month at its annual World Wide Developer’s Conference, one was of particular interest to the healthcare industry. Apple unveiled “HealthKit”, which is really a developer’s toolbox that allows makers of health and medical devices (e.g. Fitbit, UP, Misfit, iHealth) to […]
Posted in Guest Blog, healthcare, Technology | Also tagged , , , | Leave a comment

FDA Gets More Funding, IPAB Gets Less

After two years in budget limbo, Congress finally enacted federal spending legislation for fiscal year 2014 last week, just before the latest funding extension ran out. In this period of ever-tighter government outlays, the Food and Drug Administration did fairly well in gaining additional funds, along with user fee revenues that had been put on […]
Posted in FDA, healthcare, Legal, Regulatory, Safety | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta